-
Psychedelic Company Sale: Mydecine Gets Over $2.5M For Wholly-Owned Tech Subsidiary Business
Tuesday, December 13, 2022 - 2:47pm | 470Mydecine Innovations Group Inc. (OTC: MYCOF), a biotech company engineering next-gen psychedelic therapeutics, announced that it has closed the sale of all of issued and outstanding shares of its wholly-owned subsidiary, Mindleap Health Inc. to PanGenomic Health Inc., a precision health...
-
'Psyched': Silo Wellness To Go Public, MindMed Adds DMT To Research Portfolio, Champignon Closes $11M Raise, Mydecine Launches New Research Partnership
Saturday, June 20, 2020 - 3:47pm | 1123Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. Silo Wellness To Go Public With Reverse Takeover Of Yukoterre Resources Oregon-...